IFNG and immunodeficiency disease: To our knowledge, we reported the first case of malignant plasma cell disease with anti‐IFN‐γ antibody immunodeficiency syndromes that was successfully treated with anti‐plasma cell therapy, showing that such strategy was safe and effective in AOID.